AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance

AMETEK posts record Q2 results with double-digit growth across all key metrics.

What the company is saying

AMETEK, Inc. is highlighting record financial performance for the second quarter of 2026, emphasizing double-digit growth in sales, earnings, and operating income. The announcement repeatedly uses the word 'record' to frame sales of $2.04 billion, GAAP earnings of $1.77 per diluted share, and adjusted earnings of $2.09 per share as historic highs. Management, led by Chairman and CEO David A. Zapico, presents the narrative as evidence of strong execution and robust demand, particularly noting a 28% increase in orders and high free cash flow conversion. The release provides both GAAP and adjusted (non-GAAP) numbers, segment breakdowns, and forward-looking guidance for the remainder of 2026. The tone is confident and positive, with claims of 'exceptional' order growth and margin expansion, but avoids promotional or exaggerated language. Forward-looking statements are clearly separated from realised results, and the company disclaims any obligation to update projections.

What the data suggests

The disclosed numbers show a clear and broad-based improvement in AMETEK's financial performance for Q2 2026. Sales reached $2.04 billion, a 15% increase, and adjusted earnings per share rose 17% to $2.09. GAAP operating income hit $528.2 million, with adjusted operating income up 18% to $544.4 million and operating margins at 26.6%. Operating cash flow increased 35% to $483.7 million, and free cash flow conversion was strong at 111%. Orders grew 28%, indicating robust demand. Segment results were similarly strong: EIG sales rose 14% to $1.32 billion with core margins up 40 basis points, while EMG sales jumped 17% to $723.2 million and core margins expanded by 290 basis points. The company forecasts full-year 2026 sales up about 10% and adjusted EPS of $8.20–$8.30, up 10–12%. While all current period figures are disclosed in detail, the lack of prior year absolute numbers limits independent verification of the percentage increases. Overall, the data supports the company's claims of record performance and improving trajectory.

Analysis

The announcement is overwhelmingly focused on realised, measurable financial results for the second quarter of 2026, including record sales, earnings, operating income, margins, and cash flow. All key profitability and cash flow metrics are disclosed alongside revenue and operational figures, satisfying the disclosure completeness rule for a strong_positive signal. While some forward-looking guidance is provided for the remainder of 2026, these projections are clearly separated from the realised results and are not the primary focus of the release. There is no evidence of exaggerated or promotional language; the tone is positive but proportionate to the disclosed performance. No large capital outlays or long-dated, uncertain returns are discussed, and the benefits described are already being realised. The narrative is well-supported by the data, with no material gap between perception and reality.

Risk flags

• ●The announcement does not provide prior year (Q2 2025) absolute figures for key metrics such as sales, operating income, or cash flow, making it impossible to independently verify the percentage increases claimed. This limits the transparency and comparability of the reported growth rates.
• ●Qualitative descriptors such as 'exceptional' for order growth are not benchmarked against industry peers or historical averages, which could overstate the significance of the result in the absence of context.
• ●Forward-looking guidance for Q3 and full-year 2026 is not accompanied by detailed assumptions or backlog data, introducing uncertainty around the achievability of projected 10–12% EPS growth.

Bottom line

AMETEK delivered record Q2 2026 results, with double-digit growth in sales, earnings, cash flow, and orders, supported by detailed segment and margin disclosures. The company's narrative is credible, as nearly all key metrics are realised and transparently reported for the current period. The main limitation is the absence of prior year absolute numbers, which restricts independent verification of the claimed growth rates. Forward guidance for the rest of 2026 is positive but lacks detailed supporting assumptions. Investors should view these results as a strong signal of operational momentum, but would benefit from more granular historical data to fully assess the sustainability of growth. The most important takeaway is that AMETEK is currently executing at a high level, with no evidence of hype or overstatement in its reporting.

Announcement summary

(NYSE: AME) AMETEK, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting record sales of $2.04 billion, a 15% increase over the second quarter of 2025. Second quarter GAAP earnings were a record $1.77 per diluted share, while adjusted earnings reached a record $2.09 per diluted share, up 17% from the prior year. GAAP operating income was $528.2 million, and adjusted operating income increased 18% to $544.4 million, with operating margins at 26.6%, up 60 basis points from the prior year. Operating cash flow in the quarter rose 35% to $483.7 million, and free cash flow to net income conversion was 111%. Orders grew 28% in the quarter, and EIG sales were $1.32 billion, up 14%, while EMG sales were a record $723.2 million, up 17%. The company projects full-year 2026 overall sales to be up approximately 10% versus 2025 and adjusted earnings per diluted share in the range of $8.20 to $8.30, up 10% to 12% over 2025.

Disagree with this article?